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1. Introduction 
The introduction of the flexible bronchoscope by Dr. Ikeda in 1968 revolutionized 
bronchoscopy around the world. Initially, bronchoscopy was performed by surgical 
specialists with a rigid scope only in highly specialized centers, and the main indication was 
for therapeutic purposes. In the 1970s, flexible fiberoptic bronchoscopy (FFB) was learned by 
pulmonologists and surgical specialists and proved itself as a safe and useful technique for 
diagnostic and therapeutic purposes. The results have been a rapid proliferation of FFB 
inside and outside of the academic institutions.  
In the armamentarium of the pulmonary physician, FFB assumes a central position that is 
somewhere between the noninvasive diagnostic maneuvers such as physical examination, 
laboratory study, pulmonary function testing and radiologic diagnostics on one side and 
invasive surgical procedures such as mediastinoscopy and diagnostic thoracotomy on the 
other side.  
A recent trend has been the emergence of “interventional bronchoscopy” and the 
“interventional bronchoscopist”. These phrases denote a two-tier system in which one group 
of bronchoscopists perform “routine bronchoscopy” and the other performs special 
bronchoscopic procedures. Disease processes encompassed within this discipline include 
complex airway management problems, benign and malignant central airway obstruction, 
pleural diseases, and pulmonary vascular procedures. Diagnostic and therapeutic procedures 
pertaining to these areas include, but are not limited to, rigid bronchoscopy, transbronchial 
needle aspiration (TBNA), auto fluorescence bronchoscopy, endobronchial ultrasound (EBUS), 
transthoracic needle aspiration (TTNA) and biopsy, laser bronchoscopy, endobronchial 
electrosurgery, argon-plasma coagulation, cryotherapy, airway stent insertion, balloon 
bronchoplasty and dilatation techniques, endobronchial radiation, photodynamic therapy, 
percutaneous dilatational tracheotomy, transtracheal oxygen catheter insertion, medical 
thoracoscopy, and imaging-guided thoracic interventions. (Anders et al. 1988) 
Considering the prominence of FFB in the procedural armamentarium of pulmonary 
physicians (among other specialties) and the new developments of interventional 
bronchoscopy, it is important for the non-interventional pulmonologist and physician in 
pulmonary training to have a clear understanding of the role of FFB. 
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The objective of this review is to describe the place of non-interventional FFB in the practice 
of modern pulmonary and critical care medicine, to review the indications, 
contraindications and limitations of the procedure and to discuss the role of FFB in modern 
intensive care units (ICUs). The versatility of the flexible bronchoscope, combined with its 
portability, allows one to perform the technique at the bedside, and this is of major 
importance in the unstable patient, who is often unable to be transported safely to the 
bronchoscopy suite. 
2. Facilities, personnel, pre-procedure investigation and monitoring 
In order to perform a FFB, a well-equipped facility, trained personnel, pre-procedure 
evaluation, and monitoring is highly recommended. Bronchoscopies can be performed in a 
bronchoscopy suite, operating room, at the bedside and in the outpatient setting. The 
planned bronchoscopic procedures, the availability of equipment and ancillary personnel 
and resources will dictate the best and safe place for the FFB.  
Prior to the procedure, the patient’s history must be taken and a thorough physical 
examination must be given. The physician must obtain information on previous therapies 
and current performance status. Laboratory tests (e.g. complete blood count, coagulation 
profile and renal function) are usually obtained despite routine preoperative coagulation 
screening not being recommended in patients with no risk factors for complications. (Kozak 
& Brath, 1994) 
A minimum requirement is the availability of cardiorespiratory monitoring and oxygen and 
resuscitation equipment. The bronchoscopist and nursing staff should have appropriate 
training for the procedure to be performed. Conscious sedation can be administered by a 
skilled bronchoscopist or anesthesiologist. If procedures are performed under general 
anesthesia, the presence of an anesthesiologist and specialist nurse should be added. 
(European Respiratory Society/American Thoracic Society [ERS/ATS], 2002; Becker at al. 
1991) 
3. Fiberoptic bronchoscopic techniques 
Flexible bronchoscopy is preferably performed via the transnasal approach by many 
bronchoscopists after appropriate topical anesthesia and conscious sedation. A complete 
inspection of all segments of both lungs is carried out to exclude significant endobronchial 
abnormalities. The following section will describe the most common bronchoscopic 
techniques used by the non-interventional pulmonologist. 
Bronchial washings 
Bronchial washings are the secretions aspirated back through the bronchoscope channel 
after instillation of saline into a major airway. Secretions obtained by this method do not 
represent material from the bronchiolar or alveolar level and in non-intubated patients they 
may be contaminated by secretions from the upper airway.  
The main use of bronchial washings is for diagnosing pneumonia caused by strictly 
pathogenic organisms, such as Mycobacterium tuberculosis and endemic systemic fungi. In 
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Protected-specimen brushing (PSB) 
Protected-specimen brushing is a telescoping plugged catheter passed through the suction 
channel of the bronchoscope. Once beyond the tip of the scope, the internal sheet is extended, 
its gelatin plug expelled, and the sterile brush is dipped into either the visible airway 
secretions or passed more distally into the involved pulmonary segment. The brush is 
retrieved by reversal of the process, and then cut into a sterile container with 1mL of buffer or 
broth. In the microbiology laboratory, the sample is quantitatively cultured. Most investigators 
use the cutoff of 103 cfu/ml for differentiation of infection from contamination. The main value 
of PSB is for the diagnosis of bacterial pneumonia; therefore, only quantitative culture and 
possibly Gram stain of the secretions obtained by the brushing justify its use. 
Bronchial brushings 
The bronchial brush catheter is inserted in a similar way as the PSB. The cytology brush is 
stiffer than the PSB, so it makes it easier to obtain cellular material from the airway wall. The 
main indication for bronchial brushes is for the cytologic diagnosis of malignancies or viral 
inclusion bodies in airway cells. There is a slight increase in mucosal bleeding. 
Bronchoalveolar lavage (BAL) 
In comparison to bronchial washing, BAL samples a much larger airway and alveolar area. It is 
estimated that approximately 1 million alveoli (1% of the lung surface) are sampled, with 
approximately 1 ml of actual lung secretions returned in the total lavage fluid. Bronchoalveolar 
lavage requires careful wedging of the tip of the bronchoscope into the desired airway lumen, 
isolating that airway from the rest of the central airways. Wedging is defined as the position 
where the scope cannot be advanced while the distal lumen is still visible. Then, normal saline 
in 30 to 60 ml aliquots are instilled two or three times and after 2 respiratory cycles the fluid is 
intermittently suctioned out to a trap with low suction. The first 20 ml which are secretions 
found in the subsegmental bronchus is usually discarded as this is not representative of alveolar 
lavage The returned volume varies with the amount instilled but is generally 10 to 100 ml. The 
number of lavages needed is based on return and the number of tests ordered. In our institution 
the bronchoscopy nurse informs us of the adequacy of the sample. 
Bronchoalveolar lavage has been proven to be very safe and can be done without 
fluoroscopy. The diagnostic threshold for BAL fluid has been reported to be 104 cfu/ml for 
quantitative and 105 for non-quantitative cultures. Bronchoalveolar lavage is the mainstay of 
bronchoscopic diagnosis in the immunosuppressed patient when looking for an infectious 
process. In addition, BAL has diagnostic utility in eosinophilic pneumonias, pulmonary 
alveolar proteinosis, and pulmonary malignancies especially lymphangitic carcinomatosis. 
(Baughman, 2007) 
Transbronchial biopsy (TBBx) 
This technique is performed wedging the scope in the segmental bronchus of interest, and 
then passing the biopsy forceps through the working channel of the scope. Fluoroscopy can 
assist to visualize the forceps entering the pulmonary sub segment. The biopsy forceps is 
advanced to the periphery of the diseased region until resistance is met. Placement of the 
biopsy forceps near, but not at the lung surface minimizes the risk of pneumothorax. 
Subsequently, the forceps is withdrawn approximately 1 cm, and the jaws are opened and 
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advanced slightly to obtain the sample of the lung. The forceps is then advanced close to the 
area where resistance was encountered, and the jaws are closed. In case the patient reports 
pain at this point, the forceps is opened and withdrawn; only the visceral pleura is pain-
sensitive.  
The biopsy forceps is firmly retracted to obtain the sample which is placed in formalin and 
sent for histopathologic evaluation.  
Ideally, 4 to 6 transbronchial biopsy specimens should be obtained, with at least 1 sample 
containing full-thickness bronchial mucosa and some alveolar parenchyma. The number of 
biopsy specimens required for optimal diagnostic yield has been reported to be 4 to 10; BTS 
guidelines recommend 4–6 samples in diffuse lung disease and 7–8 samples in focal lung 
disease. (British Thoracic Society Bronchoscopy [BTS], 2001) 
We routinely disconnect the patient from the respirator for a couple of seconds during the 
initial part of forceps withdrawal. If there is any bleeding the scope is wedged to allow for 
clot formation. Other options include instillation of cold saline or topical epinephrine. 
Transbronchial biopsy specimens are examined by histological techniques to exclude 
infections, malignancies or other disorders. Specimens can also be placed in sterile saline 
and cultured. TBBx have been shown to increase the diagnosis of PCP in AIDS patients by 
15 %. The most important role for TBBx is probably the documentation of noninfectious 
etiologies. (Prakash at al., 1991; American Thoracic Society [ATS], 1987) 
A comparison of the yield of transbronchial biopsy specimen between standard-sized 
forceps and large forceps found no significant differences in the size of the biopsies or in the 
amount of alveolar tissue collected. (Wang et al., 1980; Loube et al., 1993) 
The tissue samples obtained by means of TBBx forceps are small, approximately 3 mm in 
size. Therefore, this procedure is not useful in diagnosing heterogeneous lung diseases such 
as idiopathic lung diseases. 
Transbronchial needle aspiration (TBNA) 
Transbronchial needle aspiration through the flexible bronchoscope was developed in the 
early 1980s for the diagnosis and staging of lung cancer. The most important indication for 
transbronchial needle aspiration is the mediastinal staging of lung cancer. The lymph node 
stations as defined by the TNM system are easily accessible with TBNA, which is cost-
effective and reduces the need for exploratory surgery. TBNA have been incorporated in the 
training of basic bronchoscopic skills. For a detailed review, the reader is directed to some 
excellent reviews on the topic. (ERS/ATS, 2002; Dasgupta & Mehta, 1999) 
To obtain a specimen, the needle assembly is introduced through the working channel of the 
bronchoscope with the needle retracted within the metal hub of the catheter. The scope is 
kept as straight as possible, with its distal tip in the neutral position. These precautions are 
necessary to prevent damaging the working channel of the scope. Once the metal hub is 
visible at the distal end of the scope, the needle is advanced and locked in place. The 
catheter is retracted until only the tip of the needle is visible at the end of the scope. The 
scope is advanced to the target, and the tip of the needle is anchored into the 
intercartilaginous space. At this stage, the goal is to penetrate the tracheobronchial wall at 
an angle as close to perpendicular as possible.  
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For peripheral lesions, TBNA should be performed with fluoroscopic guidance.  
The diagnostic yield of transbronchial needle aspiration for staging of lung cancer varies 
between 15- 83%, with a positive predictive values of 90-100%. In evaluating peripheral lung 
nodules, TBNA increases the diagnostic yield of bronchoscopy by 20-25% by facilitating the 
sampling of lesions that are inaccessible with the forceps or brush. Transbronchial needle 
aspiration has also been shown to improve the yield in the evaluation of submucosal 
disease, sarcoidosis, and mediastinal lymphadenopathy in acquired immune deficiency 
syndrome (AIDS) patients. (ERS/ATS, 2002; Dasgupta &Mehta, 1999; Wang et al., 1983; 
Ceron et al., 2007) 
In the last decades we have seen the introduction of several bronchoscopic diagnostic 
techniques which include, among others, endobronchial ultrasound, auto fluorescence 
bronchoscopy and electromagnetic navigation. The aim of these modalities is to increase the 
diagnostic yield of bronchoscopy and minimize the need for more invasive procedures.  
However, such specialized innovations are limited to specialized centers and in general do 
not reflect the application of this technique in routine clinical practice. In recent years, TBNA 
has been incorporated as a routine in the bronchoscopy suite and is part of the routine 
training of pulmonary fellows.  
The use of endobronchial ultrasound –transbronchial needle aspiration (EBUS-TBNA) is a 
relatively new, minimally invasive and an emerging diagnostic modality that has proven 
utility in the evaluation of patients with lung cancer for the assessment of mediastinal and 
hilar lymph nodes, and diagnosis of lung and mediastinal tumors. (Herth et al., 2006) 
4. Indications for flexible bronchoscopy 
The traditional and newer indications for diagnostic and therapeutic bronchoscopies permit 
greater latitude in the application of the procedure. Several reports including the North 
American survey on bronchoscopy reveals that the most common indications for 
bronchoscopy are the evaluation of suspicious lesions (nodules and masses), hemoptysis, 
pneumonia and infections, diffuse pulmonary process, and therapeutic. (Prakash at al., 1991; 
ATS,1987; Alamoudi et al., 2000) A study looking at 124 consecutive bronchoscopies, 
showed that suspicion of pulmonary tuberculosis (31%), lung mass (19%) and hemoptysis 
(18%) were the most common indications for the procedure. (Alamoudi et al., 2000) 
Although the availability of flexible bronchoscopy has been a major advance in adult 
pulmonary medicine, its role in pediatrics has remained less well defined. The most 
common indications for the procedure in the pediatric literature included stridor, abnormal 
chest roentgenogram and airway evaluation. (Brown et al., 1983; Nicolai, 2001) 
It is not uncommon to perform diagnostic and therapeutic bronchoscopies simultaneously. 
In one study of 198 bronchoscopies performed in critical care units, 47% were done for 
therapeutic reasons, 44% for diagnostic reasons, and 9% for both. (Bellomo et al., 1992) 
The major indications for diagnostic bronchoscopy are listed in Table 1. The overall yield of 
diagnostic bronchoscopy depends on the indication and the techniques used during the 
procedure and vary from 45% to 80%. The most common indication for diagnostic FFB is 
suspected malignancy, infection or tuberculosis. (Prakash at al., 1991; Joos et al., 2006) 
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Diffuse/interstitial disease in a non-immunocompromised patient  
Diffuse infiltrative pulmonary disorders in immunocompromised patients 
Unexplained cough or wheezing 
Persistent purulent sputum of unknown etiology 
Trachea/ stridor/ vocal cord paralysis/hoarseness 
Superior vena cava syndrome 
Extrapulmonary symptoms with frequent pulmonary and bronchial involvement  
Thermal/chemical injury 
Suspected tracheo-esophageal fistula 
Abnormal radiographic findings  
Evaluation of abnormal pulmonary function testing like central airway stenosis  
To evaluate complications of artificial airway 
Tracheobronchial obstruction 
Progressive or non- resolving pneumonias. 
Complications in lung transplant recipients 
Specific Indication in the ICU 
Ventilator associated Pneumonia 
Endotracheal tube placement confirmation 
Airway trauma, Bronchial stump dehiscence 
Smoke and Inhalational injury 
Double lumen intubation for independent lung ventilation 
Table 1. Indications for Diagnostic Bronchoscopy 
Indications for therapeutic bronchoscopy are listed in Table 2. Often, bronchoscopy is done 
for diagnostic and therapeutic purposes- for example patients with airway obstruction with 
placement of stent, or hemoptysis. No indication is absolutely restricted to a specific 
location; with the current portability of the bronchoscope and the advances in monitoring 
and bedside care, many hospitals provide ventilator care or advanced care to patients in 
areas other than the intensive care unit.  
 
Difficult intubation of airway and assessment of tube placement
Retained secretions and atelectasis 
Foreign body in the tracheobronchial tree 
Atelectasis/lobar collapse 
Debridement of necrotic tracheobronchial mucosa 
Dilatation of strictures and stenosis 
Pneumothorax (fibrin glue therapy) 
Delivery of brachytherapy 
Percutaneous tracheostomy 




Electrocautery / Cryotherapy 
Table 2. Indications for Therapeutic Bronchoscopy 
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4.1 Most common indications for bronchoscopy 
4.1.1 Lung cancer 
The flexible bronchoscope has become the main diagnostic tool in the evaluation of patients 
suspected of lung cancer, with more than 70% of lung carcinomas being approachable via 
bronchoscopy. Additionally, bronchoscopy plays an important role in the disease staging 
and an extended role in delivering therapeutic modalities. Regarding staging of the 
malignancy, bronchoscopy may help to determine the extension of the tumor. 
Bronchoscopic findings of vocal cord paralysis, tumor to the level of the right 
tracheobronchial junction or within 2 cm of the left tracheobronchial junction, and carinal or 
tracheal involvement are evidence of advanced stages of the malignancy.  
An advantage of flexible bronchoscopy is that it is safe, well tolerated and readily available 
in most places. The flexibility of the bronchoscope allows the inspection of most of the 
fourth order and often up to sixth order bronchi and the direct assessment of the color and 
vascularity of the mucosa.  
Routine bronchoscopic techniques include bronchial washings and lavage, brushings, and 
transbronchial biopsies. These may be augmented by the use of needle aspiration with or 
without the use of endobronchial ultrasound. It is still unclear if the combination of 
cytologic and histologic procedures provides the best diagnostic yield for lung cancer, but 
probably depends on the local expertise. (Alamoudi et al., 2000; Garg et al., 2007) 
The diagnostic yield of bronchoscopy for malignancy depends on the location and the size 
of the lesion as well as the experience of the bronchoscopist.  
Central endobronchial lesions carry the highest diagnostic yield of more than >90%, whereas 
small peripheral lesions have lower yield and usually require additional time and techniques. 
In visible, but intramural rather than endobronchial tumors, the diagnostic yield decreases to 
around 55% and is reduced further when the tumor lies beyond the bronchoscopist’s vision. 
(Mazzone et al., 2002; El-Bayoumi & Silvestri, 2008; Gasparini et al., 1995) 
The presentation of central tumors varies from an exophytic lesion, with partial or total 
occlusion of the bronchial lumen, to peribronchial tumors with extrinsic compression of the 
airway, or with submucosal infiltration of tumor. Peribronchial tumors or lesions with 
submucosal infiltration produce subtle changes in the mucosa that includes changes in 
mucosal color and vascularity, loss of bronchial markings, and nodularity of the mucosal 
surface. The yield of endobronchial biopsies is highest for exophytic lesions, with a 
diagnostic yield of approximately 90%. Central lesions are best approached with a 
combination of bronchial washes and brushings, and at least three to five endobronchial 
biopsies. 
The addition of transbronchial needle aspiration may improve the yield and should be 
considered in submucosal lesions and peribronchial disease and extrinsic compression. The 
TBNA needle should be inserted into the submucosal plane at an oblique angle, and in 
patients with peribronchial disease and extrinsic compression, the needle should be passed 
through the bronchial wall into the lesion. Occasionally, the presence of crush artifact or 
surface necrosis will give a low yield of endobronchial biopsies for this kind of lesion. 
(Schreiber & McCrery, 2003; Dasgupta & Mehta, 1999) In general, the diagnostic yield is 
increased with the use of multiple bronchoscopic techniques.  
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Peripheral lesions are usually approached with a combination of bronchoscopic techniques 
like bronchial wash, brushes, biopsies and needle aspiration. The main determinants for the 
bronchoscopic diagnostic yield for peripheral lesions include: 
- the size of the lesion: the diagnostic yield of bronchoscopy for lesions smaller than 3 cm 
varies from 14% to 50% compared with a yield of 46% to 80% for lesions larger than 3 
cm. 
- the distance of the lesion from the hilum and the relationship between the lesion and 
bronchus; a chest computed tomogram showing the presence of a bronchus sign 
predicts a higher yield of bronchoscopy for peripheral lung lesions.  
The use of fluoroscopy increases the diagnostic yield from bronchoscopy in focal lung 
lesions. Fluoroscopy carries the limitation of being time consuming, requires some 
experience, and is not readily available in all centers. A lesion that is too small and not 
visible by fluoroscopy during the bronchoscopy poses a diagnostic challenge and often 
times require further surgical biopsy procedures. Endobronchial ultrasound and 
electromagnetic navigation are exciting new technologies that could help to increase the 
diagnostic yield in those cases. (Gasparini, 1997; Cortese & McDougaIl 1979; Yung, 2003; 
Liam et al., 2007) 
The diagnostic yield of the TBBx can be significantly increased up to 73% by combining 
bronchoscopy with computed tomogram (CT) guidance in a dedicated low-dose protocol. 
The sensitivity of transbronchial biopsy for a solitary pulmonary nodule with multislice CT 
guidance has been reported to be 62.2% compared with 52.6% with fluoroscopic guidance. 
(Tsushima et al., 2006; Hautmann et al., 2010) The diagnostic yield of bronchoalveolar lavage 
alone for primary lung cancer is in the lower 30% for peripheral lung lesions. (De Gracia et 
al. 1993; Fabin et al., 1975; Fedullo & Ettensohn, 1985; Semenzato et al., 1990) 
In a study of 162 patients with malignant lung infiltrates the BAL showed increased 
sensitivity in cases of bronchoalveolar cell carcinoma (93%) and lymphangitic 
carcinomatosis (83%). (Rennard, 1990)  
The objective of staging for non–small cell lung cancer in the absence of distant metastases is 
the evaluation of mediastinal lymph node involvement. This is decisive to determine the 
prognosis and treatment plan for the patient. Nonsurgical staging includes minimally 
invasive needle biopsy techniques such as transbronchial or transthoracic needle aspiration 
and esophageal or endobronchial endoscopic ultrasound-guided fine-needle aspiration.  
The reported diagnostic yield for EBUS-TBNA of lymph nodes is as high as 93% with a 
sensitivity, specificity, and accuracy of 94%, 100%, and 94%, respectively; positive predictive 
value of 100% and negative predictive value of 11%.(Herth et al.,2006) 
A detailed discussion of EBUS if beyond the scope of this review, but the bronchoscopist 
must be aware that for those patients with known or suspected lung cancer, EBUS alone or 
in combination with EUS-FNA could likely replace more invasive and expensive surgical 
techniques. (Spiro & Porter, 2002; Gomez & Silvestri, 2009) 
The use of Rapid On-site Evaluation (ROSE) has been shown to reduce the incidence of 
inadequate specimens which is an important cause of non-diagnostic TBNA aspirates. 
Several studies showed an increase of 15 to 25% in the diagnostic yield for malignancy and a 
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decrease in the number of inadequate specimens. The overall reported diagnostic yield 
when ROSE is used is up to 80% when compared with a 50% yield when specimens are 
processed in the usual manner. The concordance between the preliminary diagnosis made 
in the bronchoscopy suite and the final diagnosis after subsequent review of material in the 
cytopathology laboratory was 87%, suggesting that ROSE of needle aspirate is fairly 
accurate but not perfect. Disadvantage of ROSE is the requirement of an expert and readily 
available cytopathologist in the bronchoscopy suite which involves extra time and effort. 
(Baram et al., 2005; Davenport, 1990; Uchida et al., 2006) 
4.1.2 Pulmonary infections 
The clinical-radiological and routine laboratory features of pulmonary infections often offer 
clues to the microbial cause of the infection, but the specific etiologic diagnosis usually 
requires the assistance of the microbiology laboratory.  
Fiberoptic bronchoscopy is frequently used as part of the diagnostic investigation of 
suspected pulmonary infections in those cases where noninvasive tests have been non-
diagnostic. The various methods used are bronchoscopic lavage, brushing, biopsies and 
occasionally TBNA which frequently are performed together to identify potential 
pathogens. Quantitative cultures of the specimen collected are performed to differentiate 
colonization from real pathogens. Rapid diagnosis is important, especially in 
immunocompromised patients.  
In the past, bronchoscopy has been used to obtain specimens for the identification of 
pathogenic organisms, such as tuberculosis, in otherwise smear-negative cases, but its role 
in the diagnosis of lung infections in general has been limited. As a consequence of the rapid 
increase in the population of immunocompromised patients due to organ transplantation, 
human immunodeficiency virus (HIV) infection and increased use of chemotherapeutic 
agents, the last decade has seen an increase in the number of patients with life-threatening 
pneumonia or resistant microorganisms.  
Community acquired pneumonia 
The role of bronchoscopy for community acquired pneumonia (CAP) is not clearly defined. 
Bronchoscopy help to retrieve specimens from the lower airway in those patients not able to 
produce sputum and, in addition, can identify endobronchial obstructions and other 
processes mimicking pneumonia.( Gross et al., 1991; Lynch & Sitrin,1993; Wintrbauer, 1995) 
In community acquired pneumonia the causative organism is not identified in more than 
40% of cases despite an aggressive search. The use of early bronchoscopy, especially prior to 
the initiation of antibiotics, has been shown to increase the identification of a specific 
microorganism. One study reported a yield of 54% to 85% with PSB for potential pathogens. 
(Jimenez et al., 1993) The use of BAL may be useful in the evaluation of pneumonia with 
quantitative cultures of specimens correlating well with PSB results. However, a more 
accurate diagnosis may not significantly change antibiotic or clinical management. 
Patients who present with severe pneumonia or who fail to improve or worsen during their 
hospitalization despite treatment with antibiotics may require further testing with 
bronchoscopy. Delayed resolution of pneumonia or suspicion of neoplasm should prompt 
the physician to perform a FFB. (Jimenez et al., 1993; Bates et al., 1992; Torres et al., 1991) 
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Progressive or non-resolving pneumonias 
Majority of patients with CAP recover after appropriate antimicrobial therapy with about 
10-15% of cases having no clinical improvement and they are categorized as non-responding 
or progressive pneumonia. (Arancibia et al., 2000) 
Progressive pneumonias are defined as actual clinical deterioration, with acute respiratory 
failure requiring ventilatory support and/or septic shock, usually occurring within the first 
72 h of hospital admission. Non-resolving pneumonias refer to absence of clinical stability 
after 3 days of antibiotics. (Mandell et al., 2007) 
Causes include host factors, inappropriate microbiological therapy (uncommon pathogens) 
and non infective causes mimicking pneumonia. Non infective differential diagnosis includes 
acute eosinophilic pneumonia, acute cryptogenic organizing pneumonia, acute sarcoidosis, 
acute hypersensitivity pneumonitis, pulmonary alveolar proteinosis and others. (Gross et al., 
1991; Lynch & Sitrin,1993; Wintrbauer, 1995) Bronchoscopy can establish the diagnosis in 
many of the infections as well as in non-infectious etiologies like acute eosinophilic 
pneumonia, diffuse alveolar hemorrhage or damage, pulmonary alveolar proteinosis, lipoid 
pneumonia, eosinophilic granulomas, and rarely rapidly progressing neoplasms. The use of 
TBBx can add additional diagnosis in selected patients. (Bulpa et al.,2003) 
Ventilator associated pneumonia 
Ventilator associated pneumonia (VAP) is a common health care associated infection, that 
develops in patients on mechanical ventilation and complicates the hospital course in 8-28% 
of patients on mechanical ventilation. (Haley et al., 1981; Pennington, 1990; Chastre & 
Fagon, 1994; Centers for Disease Control and Prevention [CDC] MMWR 2000; National 
Nosocomial Infections Surveillance [NNIS] System.1999) 
The crude mortality ranges from 30 to 50%; however attributable mortality ranges widely 
from 5.8% to 18.8%. (Esperatti et al., 2010; Nguile-Makao et al., 2010; Muscedere et al., 2008) 
Early and appropriate antimicrobial therapy has been advocated to decrease complication 
rates and mortality. (Celis et al., 1988; Luna et al., 1997; Kollef & Ward 1998)  
Chest radiographic abnormalities are common in ventilated patients and some of the 
differential diagnosis includes atelectasis, pneumonia, drug reactions, and pulmonary 
embolism. Diagnosis of VAP remains a diagnostic challenge with a potential for overuse of 
antibiotics. To aid in decision making, Pugin et al. suggested the clinical pulmonary 
infection score (CPIS); a score higher than 6 having a high predictive value for the diagnosis 
of VAP.( Pugin et al., 1991; Alvarez-Lerma, 1996; Fabregas et al., 1999; Fischer et al., 1998; 
Flanagan et al., 2000; Singh et al., 2000) A subsequent trial comparing inter observer 
variability of CPIS score for the diagnosis of VAP, revealed a sensitivity of 83% and 
specificity of 17% with a area under receiver operating characteristic (AROC) of 0.55 ,when 
CPIS score was compared with qualitative BAL fluid cultures. (Schurink et al., 2004) 
Fagon et al. reported reduced 14-day mortality with the use of a bronchoscopic bacteriologic 
strategy compared with a clinical strategy alone. (Fagon et al., 2000) 
The use of TBBx could increase the diagnostic yield especially in patients with unexplained 
pulmonary infiltrates. Bronchoscopy can aid to distinguish between colonization and 
infection in those patients. (Pechkam & Elliott, 2002) 
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Aspiration of stomach contents is a major cause of morbidity and mortality in adults and is a 
risk factor for acute respiratory distress syndrome. Bronchoscopy is indicated in patients 
with chemical pneumonia and when aspiration of a foreign body or food material is 
suspected. Aspirated material is frequently liquid in nature and disperses rapidly. Hence, 
routine FFB with lavage is not indicated. However, in the event that the aspirate is 
predominantly particulate in nature with radiographic evidence of lobar collapse or major 
atelectasis, therapeutic bronchoscopy is helpful.  
Bronchoscopy has an important role in diagnosing airway injury and confirming 
tracheobronchial damage secondary to orally aspirated caustic material. Bronchoscopy may 
be helpful in guiding antibiotic therapy. This procedure is useful when ruling out the 
presence of an obstructing neoplasm in anaerobic bacterial pneumonia with lung abscess; 
however, bronchoscopy is not useful in the treatment of community-acquired aspiration 
pneumonia. (Kollef et al., 1995; Raghavendran et al., 2011) 
Tuberculosis 
Tuberculosis (TB) remains a threat with the increased traveling, globalization, HIV 
epidemic, and immigration. Those patients suspected to have TB and who have no 
sputum or sputum smear negative for acid fast bacilli seem to benefit the most from 
bronchoscopy.  
Comparison of various bronchoscopic techniques showed that the yield of bronchoalveolar 
lavage for tuberculosis is superior to bronchial washings. Transbronchial biopsy and 
bronchial brushing cultures provided little additional diagnostic yield. Bronchoscopy can 
give immediate diagnosis when there is a positive smear from BAL fluid or caseating 
granulomas in the TBBx. Occasionally an alternative diagnosis can be found. (Venkateshiah 
& Mehta, 2003; Kobashi et al., 2007)  
Fungal infections 
Fungal infections contribute to significant morbidity and mortality in immunocompromised 
patients and bronchoscopy is useful in the diagnosis of these infections. PJP is a common 
infection in the immunocompromised and the diagnostic yield for BAL is up to 98 %. 
(Huang et al., 2006) 
Aspergillus is a colonizer of the tracheobronchial tree and tissue diagnosis is necessary for 
the diagnosis. BAL fluid may suggest the development of invasive disease (Cahill et al., 
1997), but does not establish the diagnosis. Newer techniques like BAL galactomannan 
levels which have a good sensitivity and specificity for the detection of invasive disease 
could be promising for the diagnosis (Meersseman et al.,2008; Hsu et al., 2010; Maertens et 
al., 2009); however, false-positive results are seen. (Digby et al., 2003) 
Candida is a frequent colonizer and their presence in BAL fluid may represent colonization 
rather than infection in the immunocompetent host.(el-Ebiary et al.,1997) 
In patients with non-resolving pneumonias in endemic areas, morphological and cytological 
analysis may aid in therapy of endemic mycoses like histoplasmosis, blastomycosis, 
coccidioidomycosis and paracoccidioidomycosis; however culture is diagnostic. 
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4.1.3 Diffuse lung diseases 
Interstitial lung diseases 
The interstitial lung diseases (ILDs), are a diverse group of pulmonary disorders classified 
together because of similar clinical, radiological, physiologic, or pathologic characteristics. 
The patient with suspected ILD presents a diagnostic challenge to physicians.  
The role of bronchoscopy for the diagnosis of ILD’s is limited due to the small size of the 
biopsies. Several studies have shown that the accuracy of TBBx for the diagnosis of ILD’s is 
only 7 to 37% in immunocompetent patients. (Wall et al., 1981) 
The role of FFB with BAL and TBBX in patients with diffuse lung disease is limited to the 
exclusion of infections, malignancy, sarcoidosis, eosinophilic pneumonias and 
occasionally cryptogenic organizing pneumonia. Analysis of BAL fluid can show certain 
cellular profiles that suggest specific disease processes; for example, sarcoidosis has 
lymphocytosis characterized by an increase in T-helper cells and a high CD4/CD8 ratio; 
hypersensitivity pneumonitis has T lymphocytosis, with predominance of the suppressor 
subset CD8; and idiopathic pulmonary fibrosis is characterized by increases in 
neutrophils and eosinophils. Unfortunately, the BAL findings have limited clinical utility 
for the diagnosis, prognosis or as a guide to therapy in patients with ILD’s. Using TBBx to 
diagnose idiopathic ILD’s is not recommended. Surgical lung biopsy remains the 
investigation with the greatest overall diagnostic sensitivity for ILD’s. (ATS/ERS, 2002; 
Talmadge, 2005) 
Diffuse infiltrative pulmonary disorders in immunocompromised patients 
Immunocompromised hosts include patients with AIDS, bone marrow and other transplant 
recipients, patients on chemo or radiation therapy, and patients on immunosuppressive 
therapy. These patients can be acutely ill and present often with progressive hypoxia. 
(Pechkam & Elliott, 2002). Differential diagnosis in this group includes both infective and 
non infective causes. Infective causes are viral and PJP infections, atypical pathogens, fungal 
and parasitic infections. Non-infective causes include graft rejection, toxicity secondary to 
radiation or chemotherapy, diffuse alveolar damage and diffuse alveolar hemorrhage. Rapid 
progression of the illness is not uncommon with the need for mechanical ventilation. 
Diagnostic delay in this group increases mortality and bronchoscopy can be very useful in 
the early diagnosis and management of these patients. 
Lung transplant recipients 
The number of transplant patients continues to grow and their care is not limited to 
specialized centers. They can present with a wide range of pulmonary disorders and 
causes of respiratory deterioration in transplant patients include rejection or infections. 
Bronchoscopy remains a valuable tool in this setting. FFB with BAL and TBBx has high 
sensitivity for the diagnosis of PJP, CMV and rejection. (Bulpa et al., 2003) The presence of 
Aspergillus in BAL fluid though non-diagnostic is predictive of development of invasive 
disease. (Cahill et al., 1997) Therapeutic bronchoscopic interventions include dilatation 








Retained secretions and atelectasis 
Atelectasis is a frequent complication seen in the ICU and retained secretions and atelectasis 
remains a common therapeutic indication for bronchoscopy. Although the use of FFB in 
situations of whole lung collapse associated with hypoxia is well established, there are no 
definitive guidelines in other situations. Bronchoscopy is usually performed when 
suctioning and chest physiotherapy fails to result in aeration of involved lungs. Stevens et al 
reported that 93 (79 %) of 118 bronchoscopies performed for atelectasis resulted in 
improvement compared with 31 (44%) of 70 patients with retained secretions. (Stevens et al., 
1981) Other studies have reported a success rate between 19% to 81%. (Weinstein et al., 1977; 
Lindholm et al., 1974; Snow& Lucas, 1984) 
In a prospective study Marini et al reported that the presence of air bronchograms on the 
initial chest roentgenogram predicted delayed resolution of atelectasis. (Marini et al., 
1979).In this situation bronchoscopy may not be beneficial. 
Bronchoalveolar lavage may aid in the resolution of atelectasis and identify some 
pathogenic microorganisms. In addition, bronchoscopy allows the instillation of mucolytic 
agents. We suggest bronchoscopy in critically ill patients with lobar or whole lung collapse 
without air bronchograms if chest physiotherapy is unsuccessful.  
Removal of foreign bodies 
Foreign body (FB) aspiration is frequently suspected in children with acute or recurrent 
pulmonary symptoms, but it is rarely considered in adults with acute or chronic respiratory 
symptoms unless a clear history of aspiration can be obtained. Food items are the most 
common aspirated FB with peanuts and animal or fish bones being the most common ones. 
The most common presentation is chronic cough, hemoptysis, dyspnea, and fever. If the FB 
is not removed, then more persistent findings may be seen such as atelectasis, post 
obstructive pneumonia, bronchiectasis, or lung abscess, and/or emphysema. The exact 
incidence of FB aspiration in adults is not known. Some studies report that only 7% of 
patients present with a history of choking (Chen et al., 1997). 
Any condition leading to diminished swallowing reflex places the patients at risk for FB 
aspiration. Bronchoscopy is a valuable tool for the diagnosis and retrieval of the FB. 
Instruments used in retrieval include alligator and biopsy forceps, wire baskets and retrieval 
forceps. Overall success rates for retrieval of FBs ranges from 61 to 89% for both flexible and 
rigid bronchoscopies. (Limper &Prakash, 1990; Debeljak et al., 1999; Cunanan, 1978; Lan et 
al., 1989) FFB is probably more useful for FB in distal segments beyond the reach of rigid 
bronchoscope. In some cases, flexible and rigid bronchoscopy are complementary, with FFB 
assisting in the localization of the FB and then retrieval done with the rigid bronchoscope. 
Significant tissue reaction with inflammation is commonly seen in the delayed cases at 
bronchoscopy. Innovative anecdotal use of cryotherapy instruments to remove some foreign 
bodies have also been described. 
Difficult intubation 
Approximately 1% to 3% of tracheal intubations prove to be difficult with standard 
techniques. This is especially true as all invasive airway maneuvers can be considered 
difficult in a critically ill patient, either in the ICU or other setting. (Schwartz et al.,1995) 
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Fiberoptic intubation is a key aspect in the management of difficult intubations and forms 
part of several difficult airway algorithms (Benumof, 1991; American Society of 
Anesthesiologists, 2003; Crosby et al., 1998; Henderson et al., 2004) Intubation in these 
instances is performed using the bronchoscope as an obturator. Care must be taken to use a 
bite guard or an oral airway as damage to the scope by patient bites should be avoided. 
Hemoptysis 
Massive hemoptysis, defined as the volume of expectorated blood that is life-threatening 
due to hypoxia from airway obstruction or hemodynamic instability from blood loss, 
accounts for 4.8% to 14% of all patients with hemoptysis. (Dweik & Stoller, 1999) 
Massive hemoptysis remains an emergent indication for bronchoscopy. The primary 
intention is to locate the source of bleeding and if possible to control it by use of topical or 
endobronchial tamponade. Control of bleeding can be achieved by topical application of 
cold saline or diluted 1: 1000 epinephrine; other agents include application of thrombin or 
fibrinogen–thrombin combination. (Tsukamoto et al., 1989) 
Endobronchial tamponade can be achieved using a Fogarty balloon or rarely a pulmonary 
artery catheter. In rare instances bronchoscopic guided contralateral lung intubation is life 
saving. Localization of the bleed helps in the planning of bronchial artery embolization or 
thoracotomy. 
Bronchopleural fistula 
In patients with persistent air leaks and suspected broncho-pleural fistula (BPF), 
bronchoscopy can help define the extent of the broncho-pleural fistula and differentiate 
between stump dehiscence and a distal parenchymal leak. In addition, BPF associated with 
pneumonectomy or lobectomy can be directly visualized. In patients with suspected distal 
BPF a careful sequential inspection of each bronchopulmonary segment should be 
performed; this usually requires the use of balloons to occlude the bronchial segments to 
locate the one leading to the fistula and then apply sealants. (Lan et al., 1987; Regel et al. 
1989; Lois & Noppen,2005; Oren et al., 2011) 
Other indications include confirmation of endotracheal tube (ETT) placement, double lumen 
ETT placement, diagnosis of bronchial rupture or bronchial stump dehiscence. Less 
common indications include inspection of upper airway prior to extubation when edema or 
other anatomical problems are expected in an intubated patient. In such instances, 
extubation can be attempted under bronchoscopic guidance and reintubation if necessary 
can be easily done using the bronchoscope as a guide wire. Bronchoscopy in indicated in 
patients with smoke inhalation to categorize the extent of injury and the need for intubation 
and in the presence of glottic and subglottic edema, intubation can be performed safely 
under bronchoscopic guidance.  
4.1.5 Bronchoscopy in special circumstances 
Bronchoscopy in patients with renal impairment 
Uremia has been reported to be associated with an increased risk of bleeding, mainly due to 
platelet dysfunction. (Cordasco et al., 1991)A 45% incidence of pulmonary hemorrhage after 
bronchoscopic lung biopsy was documented in immunosuppressed uremic 
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patients.(Cunningham et al., 1977) A more recent study looking at 72 patients with renal 
insufficiency reported a much lower rate of bleeding complications with TBBx. There were 
no complications in the hemodialysis (HD) group and only one of 25 (4%) patients not on 
HD had a bleeding complication. (Mehta et al., 2005) 
These findings suggest the possibility that the risk of bleeding in patients with renal 
insufficiency undergoing TBBx is lower than initially reported. Those patients should be 
screened for coagulation abnormalities and, if receiving HD, the TBBx should be done after 
HD with pre-bronchoscopy administration of 1-deamino-8-D-arginine vasopressin 
(DDAVP).Platelet transfusions, infusion of cryoprecipitate or DDAVP, administration of 
analogues or derivatives of vasopressin and administration of estrogen are some of the 
strategies implemented to decrease bleeding complications during FFB. (Cordasco et al., 1991)  
Bronchoscopy in patients with cardiac ischemia 
Hypoxia is a relatively common complication of FFB, which may predispose to cardiac 
arrhythmias. (Katz et al., 1981) Cardiovascular stress and hypertension are common and can 
result in cardiovascular changes during bronchoscopy especially if they have cardiac risk 
factors.( Davies et al.,1997) Acute myocardial infarction (AMI) is generally considered to 
increase the risk of FFB. A retrospective study concluded that bronchoscopy is safe in the 
immediate post-AMI period as long as the patient does not have active ischemia at the time 
of the procedure; the mean period between the AMI and FFB was 11.7 days. The risks of 
bronchoscopy are thought to be reduced 4–6 weeks after myocardial infarction. (Dweik et 
al., 1996; Kvale, 1996; American College of Cardiology and American Heart Association 
Taskforce, 1996; Dunagan et al., 1998; Bein &Pfeifer, 1997) 
Bronchoscopy in patients with obstructive airway disease 
Asthma has been associated with laryngospasm or bronchospasm complicating 
bronchoscopy. The reported incidence of bronchoscopy induced bronchospasm ranges from 
0.02% to 8%. Decrease in FEV1 is seen during FFB and this is more pronounced in asthmatics 
compared to non asthmatics. In patients with mild asthma, pre procedure use of 
bronchodilator has not been associated with a decrease in the postoperative FEV1, however, 
the use of pre-bronchoscopy bronchodilator is associated with blunting of the post 
bronchoscopy decrease in FEV1 in asthmatics with more severe disease.( Fish & Peterman 
1979; Djukanovic et al., 1991;Van Vyve et al., 1992; Rankin et al., 1984; Mavritsyn & Lifshits, 
1980) In a large multicenter study of over 20,000 bronchoscopies, bronchospasm was 
reported in 0.004% of all the procedures.(Facciolongo et al., 2009) In general, it is 
recommended that patients with asthma receive bronchodilator nebulizers before the 
procedure; taking in consideration that the benefit have been reported mainly in the most 
severe asthmatic.  
The presence of severe chronic obstructive pulmonary disease (COPD) has been shown to 
increase the complication rate of bronchoscopy. The complication rate is as high as 3% to 5% 
in severe COPD (FEV1 /FVC <50% or FEV1 <1.2 L) when compared with 0.6% of patients 
with normal lung function. An arterial blood gas should be considered prior to 
bronchoscopy for those patients with severe COPD. The judicious use of sedation and 
monitoring of oxygenation and ventilation permit the safe performance of FFB in selected 
patients with COPD.( BTS, 2001; Peacock et al., 1994; Hattotuwa et al., 2002) Although there 
is no data regarding the use of pre-procedure bronchodilators in COPD, we routinely use 
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bronchodilators prior to the bronchoscopy and monitoring is done with pulse oximetry and 
end tidal CO2 (ETCO2).  
Bronchoscopy in the elderly 
Epidemiologic studies have shown a trend in the increase of the “oldest old” or those 85 years of 
age or older from the absolute number of 3.5 million as measured in 1990 to approximately 15.3 
million persons in the year 2050. Proportionately to this trend, this age group might comprise a 
portion of the population that could need diagnostic and therapeutic bronchoscopy. 
A study of FFB in 107 octogenarians revealed no difference in procedural indications, 
complication rates, or diagnostic yield between octogenarians and non-octogenarians. 
Despite a significantly lower doses of sedation used in octogenarians, they experienced a 
predominant complication of oversedation. (Patrick et al., 2003; Knox et al., 1988) 
Raised intracranial pressure 
In patients with head injuries, brain tumor or massive stroke, the increase in the intracranial 
pressure (ICP) can be significant; (Snow& Lucas, 1984, Lee, 1994; Peerless et al., 1995) raising 
concerns about the safety of bronchoscopy in this setting. A potential complication of 
bronchoscopy includes an increase in the ICP due to the manipulation of the airways 
especially during suctioning and excessive coughing. (Rudy et al., 1991) Kerwin et al 
reported an increase in ICP during bronchoscopy, the concomitant increase in MAP 
maintained CPP but the increase in MAP was not linear and there was no persistent increase 
in ICP after the procedure. (Kerwin et al 2000) They suggested that pharmacologic paralysis 
and heavy sedation should be used and that the bronchoscopy should be performed in the 
minimum amount of time possible. In general, bronchoscopy carries a low risk in patients 
with raised ICP in patients with intracranial space occupying lesions. (Bajwaet al., 1993)  
Bronchoscopy in pediatric population 
Although the availability of bronchoscopy has been a major advance in adult pulmonary 
medicine, the role of FFB in pediatrics has remained less well defined. The last 20 years has 
seen an increase in the use of FFB for the evaluation of respiratory disorders in children. 
(Nicolai, 2001; Barbato et al., 1997) The main indications for bronchoscopy in children 
includes the evaluation of stridor, persistent wheezing, or a suspected foreign body, 
abnormal chest roentgenogram, airway evaluation in patients with tracheostomy, airway 
obstruction , hoarseness, recurrent pneumonia , chronic cough and hemoptysis.  
Overall, the diagnostic yield in this population has been reported in the range of 75% to 88% 
of cases. (Brown et al., 1983; Wood, 1985; Martinot et al., 1997)  
Several studies looking at the safety of bronchoscopy in the pediatric population have 
reported a low complication rate of less than 2%. De Blic study in 1328 children that 
underwent FFB under conscious sedation reported 5.2% of minor complications which 
included moderate and transient episodes of desaturation, excessive coughing and nausea, 
transient laryngospasm and epistaxis. Major complications were seen in 1.7% of cases and 
included oxygen desaturation to less than 90%, laryngospasm and bronchospasm, and 
pneumothorax.( J. de Blic et al 2002) The high diagnostic yield and low complication rate 
strongly support the use of the FFB in the diagnostic evaluation of infants and children who 
have a variety of pulmonary problems.( Wood, 1984, 1985) 
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5. Bronchoscopy in the intensive care unit 
Respiratory involvement is common in the critically ill patient in the intensive care unit 
(ICU) with 30 to 50% of the admissions requiring the use of mechanical ventilation. 
Fiberoptic bronchoscopy remains a very valuable tool in the evaluation and management of 
these patients as well as to evaluate complications of mechanical ventilation especially 
atelectasis and ventilator associated pneumonias (VAP). Bronchoscopy in the ICU plays a 
role as a diagnostic and therapeutic tool. Many of the indications for bronchoscopy in the 
ICU overlap with the general indications for the procedure as discussed above.  
Bronchoscopy on patients on mechanical ventilation 
The routine FFB with BAL is frequently performed in patients on mechanical ventilation 
(MV). Use of transbronchial biopsy in this group of patient’s remains low and underutilized 
probably due to the lack of fluoroscopy in the ICU setting. 
In a non intubated patient a regular 5.7 mm bronchoscope usually occupies 10 % of the 
tracheal cross sectional area and is of no physiological consequence. The consequences on 
the respiratory mechanics have been described in detail by Jollier and Chevrolet. (Jolliet & 
Chevrolet 1992) . A 5.7 mm internal diameter bronchoscope occupies 40% of the total 
cross-section of a 9 mm internal diameter ETT, 51 % of an 8 mm ETT, and 66% of a 7 mm 
ETT. This results in the development of intrinsic PEEP and as described, smaller the tube, 
higher the development of PEEP with the consequent increase in airway pressures. 
Additionally, functional residual capacity increases by 30% and forced expiratory volume 
in one second (FEV1) decreases by 40%.( Matsushima et al.,1984) The decrease in the 
delivered tidal volume leads to hypoventilation and gas exchange abnormalities resulting 
in hypoxia and hypercapnea. Suctioning during bronchoscopy limits the delivered tidal 
volume further and up to 200 to 300 ml of delivered volume can be removed with each 
suctioning. It is therefore recommended that an ETT of at least size 8 or 8.5 mm be used 
when performing bronchoscopy in intubated patients. (Grossman& Jacobi, 1974; Jolliet & 
Chevrolet 1992))  
Cardiovascular consequences of bronchoscopy include arrhythmias secondary to vagotonic 
effects, hypoxia or hypercapnea. Increased intrinsic PEEP can result in impaired preload 
and hypotension. Adjustments needed prior to bronchoscopy in a patient on MV include 
preoxygenation with 100% oxygen and increase in the tidal volume by 30%. Bronchoscopy 
should be performed on 100% FIO2 and this should be continued into the post bronchoscopy 
period. Peak airway pressure alarm limit should be increased before the procedure to 
account for the increase in pressure on introduction of the scope and ensure delivery of 
adequate tidal volume and adequate ventilation. It is our personal experience to withdraw 
the scope and allow for ventilation when the SpO2 reaches 90%. In patients who have acute 
or chronic pre-procedure hypercapnia, the use of ETCO2 monitoring is helpful. 
Bronchoscopic techniques used for procedures done at the bedside of the patient in the ICU 
are similar to the ones done in the bronchoscopy suite.  
Bronchoscopy in mechanically ventilated patients – A bed side approach 
1. Review the indication for bronchoscopy and review imaging before the procedure 
2. Obtain informed consent 
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3. Inspect the ETT or tracheostomy size. If ≥ 8mm then a standard 5.7mm outer diameter 
bronchoscope can be used. If the artificial airway tube is smaller, then a smaller size 
scope is needed. Shorten the ETT by cutting the distal end to facilitate inspection of the 
distal tracheobronchial tree. Attach Portex adapter to facilitate ventilation during 
bronchoscopy. Oral airway or bite guard is recommended to prevent trauma to the 
scope. 
4. Increase FiO2 to 100 percent 15 minutes before the procedure and make ventilator 
adjustments. In volume assist modes the peak pressure limit is increased and in 
pressure control assist mode the pressure control needs to be increased to compensate 
for the increased resistance generated due to the insertion of the scope. 
5. Time out and sedation as per hospital policies. On patients with sedative infusion drips, 
an initial bolus is recommended 
6. Document peak air way pressure before procedure 
7. Patient should be monitored with continuous EKG, SpO2 and ETCO2 for those with 
hypercapnea. Blood pressure should be monitored every 5 minutes during the 
procedure 
8. Lubricate bronchoscope and insert into the ETT/tracheostomy via the adapter. Topical 
anesthesia is achieved with topical lidocaine application into the trachea, carinal and 
main stem bronchi. Recommended maximal dose of lidocaine is 4-5 ml/kg ideal body 
weight or 300 mg per procedure. Minimal use of suction to prevent loss of tidal volume. 
Restrict suctioning to less than 3 seconds. 
9. After inspection of the tracheobronchial tree, BAL is performed. The exception to this 
rule is suspected infection, in which case locate the bronchopulmonary segment of 
interest and perform lavage. This decreases the chances of contamination of the 
specimen. 
10. The BAL is performed as described under bronchoscopic techniques.  
11. To perform the TBBx, apply topical lidocaine to the segment of interest and perform 
biopsy as described under techniques. We take special care that the patient is well 
sedated and not fighting the ventilator or coughing excessively. We routinely 
disconnect patient from the respirator for a couple of seconds during initial part of 
forceps withdrawal. If there is any instability pull out the scope and ventilate patient. 
Bronchoscopy can be continued after the situation resolves. 
12. Post procedure check peak airway and plateau pressure and obtain a chest 
roentgenogram to evaluate for complications. 
Diagnostic yield of bronchoscopy in mechanically ventilated patients 
The diagnostic yield of FFB depends on the indication and the comorbid clinical status. 
Different bronchoscopic techniques are associated with different diagnostic yield in this 
group of patients.  
Protected brush 
Pooled results of 18 studies of PSB technique was evaluated in a total of 795 critically ill 
patients. The overall accuracy of this diagnostic method for diagnosing health care 
associated pneumonia (HCAP) was high, with a sensitivity of 89% and a specificity of 94%. 
Prior anti microbial therapy decreases the diagnostic yield. (Chastre & Fagon, 2002) 
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Torres & el-Ebiary reviewed 23 studies that evaluated the accuracy of BAL to diagnose VAP 
in a total of 957 patients. In this review, BAL had a mean sensitivity of 73% (range 22 to 
100%) and mean specificity of 82%. The presence of intracellular organisms in BAL was 
specific for VAP. (Torres & El-Ebiary 2000) 
In patients with AIDS, BAL had a diagnostic accuracy of 89 to 98% in the diagnosis of PJP. 
(Huang et al., 2006) In a prospective multicentre trial in hematology and oncology patients 
there was no difference between bronchoscopic BAL versus other strategies in establishing 
diagnosis. (Azoulay et al., 2008) However, FFB-BAL was the only conclusive investigation in 
a third of patients and induced respiratory deterioration in about half of these cases. A 
subsequent study by the same investigators showed that noninvasive testing alone was not 
inferior to noninvasive testing plus FFB-BAL within 24 hours of admission for the 
identification of the cause for acute respiratory failure. (Azoulay et al., 2010) 
In neutropenic patients with pulmonary infiltrates, the diagnostic yield of BAL was 49% 
with low complication rates; there were infrequent treatment changes and there was 
improved survival.( Gruson et al., 2000) 
TBBx 
In patients with diffuse unexplained pulmonary infiltrates, combined BAL and TBBx 
resulted in diagnosis in 74% of patients and the authors concluded that the benefits of the 
procedure exceeded the risks. (Bulpa et al 2003) TBBx is useful in distinguishing infections 
from rejection in lung transplant patients.  
Management of critically ill patient on mechanical ventilation with unclear lung findings 
represents a challenge to the clinician. In cases where FFB-BAL and all noninvasive studies 
have been non diagnostics, TBBx or surgical lung biopsy is recommended. This is 
compounded by the fact that there are few studies looking into the role of TBBx in ventilated 
patients. (Papazian et al., 1998) 
6. Safety and contraindications of bronchoscopy 
Flexible bronchoscopy is an extremely safe procedure with a low incidence of 
complications.(Dweik et al., 1996; BTS, 2001;Prakash at al., 1991;ATS,1987) One study 
reported a mortality rate of 0.01% and a major complication rate of 0.08% in a series of 24521 
procedures, and another a mortality of 0.02% and a 0.3% rate of major complications in a 
series of around 48 000 cases. (Kvale, 1996; Zavala, 1975; Credle et al., 1974; Pue & Pacht, 
1995; Surrat et al., 1979) 
A multicenter, prospective study describing the practice of bronchoscopy in the United 
States revealed adverse events in 35% of cases, most of them mild (sore throat 10%, 
hemoptysis 8%, bleeding 4%, cough 3%). Severe adverse events occurred in 10% and 
included hospitalizations for cardiac arrhythmias, exacerbation of chronic obstructive 
pulmonary disease, and hypoxia. The mortality rate was 2% , a rate higher than previously 
reported. (Bechara et al., 2005)  
Major life threatening complications include respiratory depression, pneumonia, 
pneumothorax, airway obstruction, cardio-respiratory arrest, arrhythmias, and pulmonary 
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edema. Major complications are partly because of the cardiovascular effects of 
bronchoscopy, leading to an increase in blood pressure and heart rate causing arrhythmias 
and cardiovascular ischemia. Oxygen desaturation can occur because of the procedure itself 
or respiratory depression by sedative drugs leading to hypoxemia and increased risk of 
arrhythmias and ischemia. Bronchoscopy is performed in different settings, varying from 
local to general anesthesia with intubation; the choice of the way in which the bronchoscopy 
is performed is more a matter of personal experience and choice than of evidence-based 
medicine. Comparison of rigid bronchoscopy under general anesthesia and flexible 
fiberoptic bronchoscopy reveals that FFB with topical anesthesia has a safer profile than 
rigid bronchoscopy. (BTS, 2001; Hattotuwa et al., 2002; Surrat et al., 1979; Pereira et al., 1978; 
Lundgren et al.,1982; Davies et al.,1997) 
Minor non-life threatening complications include, in order of frequency, vasovagal 
reactions, fever, cardiac arrhythmias, hemorrhage, nausea and vomiting. Post-bronchoscopy 
fever occurs in approximately 5% to 16% of the patients, with pulmonary infiltrate occurring 
in 0.6% of all cases. The self-limiting fever is usually not indicative of pneumonia and may 
be due to transient bacteremia, translocation of endotoxins or release of inflammatory 
mediators. (BTS, 2001; Pereira et al., 1978; de Castro & Violan,1996) 
Complication rates that are related specifically to the procedure of transbronchial biopsies 
are higher, with pneumothorax reported in 1 to 5% of cases and mild hemorrhage in 9%. 
(Bechara et al., 2005; Zavala, 1978; Hanson et al., 1976) 
6.1 Pneumothorax 
Pneumothorax is very uncommon after FFB; however, a major pneumothorax requiring 
drainage has been reported to occur in 3.5% of FFB with TBBx. The incidence of 
pneumothorax with TBBx is as high as 14% for patients on mechanical ventilation. 
Symptoms and/or signs of a pneumothorax may be delayed after TBBx but it is very 
uncommon for a pneumothorax to develop after an hour of TBBX. (Lindholm et al., 1974) 
About 50% of patients who develop pneumothorax will require drainage. 
6.2 Fluoroscopy for bronchoscopy 
The use of fluoroscopy does not appear to reduce the frequency of pneumothorax, especially 
in non-mechanically ventilated patients. (Zink et al., 2007; O’Brien et al., 1997; Milman et al., 
1993) Literature regarding non fluoroscopy guided transbronchial biopsy in patients on 
mechanical ventilation is scarce. In most of the ICU’s fluoroscopy is not available which 
limits the use of TBBx in mechanically ventilated patients. In smaller series, the rate of 
pneumothorax varies from 12 to 27% (Bulpa et al.,2003; Pincus et al., 1987;) and 10.4% in 
larger series ( O’Brien et al., 1997). Risk of pneumothorax is directly proportional to the 
number of biopsies attempted; Descombes et al reported 38% and 69% yields with 1–3, and 
6–10 specimens, respectively. (Descombes et al., 1997) 
At our institution, we perform 1-3 biopsies on patients on mechanical ventilation without 
the use of fluoroscopy; otherwise, to obtain more biopsies we do the procedure in the 
operating room under fluoroscopic guidance.  
In general, the use of fluoroscopy increases the diagnostic yield from TBBx in focal lung 
lesions. Fluoroscopy carries the limitation of being time consuming, requires some 
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experience, and is not readily available in all centers. (Gasparini, 1997; Cortese & McDougaIl 
1979; Yung, 2003; Liam et al., 2007) 
6.3 Bleeding complications 
Several studies have shown that patients with uremia, immunosuppression, pulmonary 
hypertension, liver disease, coagulation disorders, or thrombocytopenia have a higher risk 
for hemorrhage with transbronchial biopsy(TBBx). (Papin et al., 1985; Zavala, 1976; Borchers 
& Beamis 1996) 
The risk of bleeding during TBBx seems to be unrelated to the size of forceps and is slightly 
higher in those being mechanically ventilated. (Loube et al., 1993; O’Brien et al., 1997)  
In patients with a potential increased risk of bleeding, coagulation profile should be checked 
before bronchoscopy. There is no information about what constitutes a “safe” level for 
clotting in this context. Transfusion guidelines and expert opinions recommend platelet 
counts of 20,000–50,000/mm3 for FFB with BAL and greater than 50,000/mm3 for TBBx. It is 
recommended that platelets be transfused following those guidelines. (Rebulla, 2001) 
Thrombocytopenia (platelet count <150.000 mm3) is seen in 35 to 40% of critically ill medical 
patients (Vanderschueren et al., 2000; Strauss et al., 2002), with surgical and trauma patients 
having a higher incidence of thrombocytopenia. ((Stephan et al., 1999) 
Patients with coagulopathy are at a high risk for bleeding with brushings and biopsy; Weiss 
et al., reported 12% of complications in patients with significant thrombocytopenia after 
bronchoscopy with BAL, but serious complications were rare. (Weiss et al., 1993)  
In patient taking oral anticoagulants, published guidelines for managing anticoagulation in 
the perioperative period are relevant. These state that “the short term risk of 
thromboembolism in patients with mechanical heart valves when not anticoagulated is very 
small”. (Brickey & Lawlor, 1999; British Committee for Standards in Haematology, 1998) 
In patients on anticoagulation undergoing transbronchial biopsy, unfractionated heparin 
drips should be stopped 6 hours prior and low molecular weight heparin should be held the 
evening prior and on the day of the procedure 
The use of aspirin alone in humans has not been associated with an increase in bleeding 
complications from TBBx and therefore there are no recommendations to stop the 
medication before this procedure. (Herth et al., 2002)  
The data from aspirin cannot be generalized to clopidogrel use because its mechanism of 
action differs from that of aspirin. Several studies indicate an increased risk of bleeding 
when clopidogrel is combined with other antiplatelet drugs. (Hongo et al., 2002; Yende & 
Wunderink, 2001) A study in 604 patients without underlying coagulation problems who 
underwent TBBx while on clopidogrel with or without aspirin revealed an increased risk 
of bleeding after the lung biopsy. Marked bleeding was observed in most patients 
receiving clopidogrel and in all patients receiving clopidogrel combined with aspirin. On 
the basis of these results, it is recommended that clopidogrel should be stopped 5 to 7 
days before TBBx to ensure patient safety. The indications for TBBx need to be clearly 
defined, as it means stopping a beneficial medication for patients with cardiovascular 
diseases. (Ernst et al., 2006) 
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The contraindications to bronchoscopy must always be considered in relationship to the 
expected benefits and clinical consequences. The determining factors are, in addition to the 
clinical status and prognosis of the patient, the technical difficulties of the procedure, and 
the skills and experience of the endoscopist. There are no controlled studies of the factors 
which may make a patient totally unfit for the procedure, so a decision to perform a 
bronchoscopy is a balance between the likely benefit of obtaining diagnostic material 
(including therapeutic benefit) and an assessment of the likely risk for complications in that 
individual patient. (BTS, 2001; ATS, 1987; Ernst et al.,2003; Wood-Baker et al., 2001) 
Relative contraindications to bronchoscopy include severe respiratory insufficiency when 
bronchoscopy will be non-therapeutic, inability to maintain a patent airway and severe 
cardiovascular instability. Coagulopathy when biopsy is considered and severe generalized 
debilitated status are other relative factors to be considered prior to bronchoscopy.  
Careful planning and taking all appropriate precautions prior to the bronchoscopy cannot 
be overemphasized in those patients with myocardial infarction within the last 4 weeks and 
patients with severe hypoxemia who could benefit from intubation prior to the 
bronchoscopy.  
For those patients with severe renal or coagulation impairment, transmissible infection (e.g. 
active pulmonary tuberculosis) and the very uncooperative patient the benefit of the 
procedure must be weighed carefully. 
Additionally caution is advised in patients on mechanical ventilation with high PEEP, 
hypoxia requiring high supplemental oxygen and electrolyte abnormalities. In unstable 
patients it is recommended to stabilize the respiratory status before FFB and this may 
include intubation and mechanical ventilation. (Crosby et al.,1998; Henderson et al.,2004; 
Alamoudi et al.,2000;Becker at al., 1991) 
7. Conclusion 
The development of flexible bronchoscopy in the late 1960s revolutionized the care of 
patients with lung and airway problems. The flexible bronchoscope has almost completely 
supplanted the rigid scope for the routine diagnostic evaluation of lung diseases. The 
technique is acceptable to the patient, is safe and allows a more complete examination of the 
bronchial tree and is ideal for a variety of other diagnostic procedures such as 
transbronchial biopsy, bronchial lavage and needle aspiration. Bronchoscopy remains a very 
valuable tool for both diagnostic and therapeutic procedures for a variety of respiratory 
conditions encountered in clinical practice including in critically ill patients. Bronchoscopy 
has a definite diagnostic role in those patients suspected of having pulmonary malignancy 
or some diffuse lung diseases like sarcoidosis and infections in the immunosuppressed host. 
In experienced hands, the bronchoscope is an invaluable diagnostic and therapeutic tool in 
the ICU that at present is probably underused. 
Appropriate indication, experience of the bronchoscopist and careful attention to detail 
results in a high diagnostic yield with a low complication rate even with the inclusion of 
needle aspiration and biopsies. The current advances in technology, imaging and 
information processing continue to improve the ability to perform minimally invasive, 
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accurate evaluations of the tracheobronchial tree and to perform an ever-increasing array of 
diagnostic, staging, therapeutic, and palliative interventions. 
We believe that a well trained pulmonologist should continue using the bronchoscope in 
order to diagnose the most commonly encountered pulmonary conditions. The idea of 
having an “optimal bronchoscopist” who is highly skilled in all the bronchoscopic 
techniques and able to handle flexible and rigid scope in adults and pediatric population as 
Prakash and Stubbs discussed in their 1994 publication is probably not feasible at this point 
on time. (Prakash & Stubbs 1994) Pulmonologists need to be able to identify those patients 
that could benefit from more invasive or sophisticated bronchoscopic procedures and refer 
them to centers of excellence with an interventional pulmonologist. 
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